CTKB FY 2021 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$128M+37.8% YoY

Gross Profit

$79M61.9% margin

Operating Income

$9M7.2% margin

Net Income

$3M2.3% margin

EPS (Diluted)

$0.03

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$266,000

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$463M

Total Liabilities

$58M

Stockholders' Equity

$405M

Cash & Equivalents

$365M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$128M	$93M	+37.8%
Gross Profit	$79M	$52M	+53.1%
Operating Income	$9M	$14M	-33.0%
Net Income	$3M	$19M	-84.5%